Cited by 134Sexual Differentiation and DisordersAdrenal Hormones and DisordersOvarian function and disorders

Management of adolescents with congenital adrenal hyperplasia

Open access
Merke, Deborah P, Poppas, Dix P·2013·The Lancet Diabetes & Endocrinology

Abstract

The management of congenital adrenal hyperplasia involves suppression of adrenal androgen production, in addition to treatment of adrenal insufficiency. Management of adolescents with congenital adrenal hyperplasia is especially challenging because changes in the hormonal milieu during puberty can lead to inadequate suppression of adrenal androgens, psychosocial issues often affect adherence to medical therapy, and sexual function plays a major part in adolescence and young adulthood. For these reasons, treatment regimen reassessment is indicated during adolescence. Patients with non-classic congenital adrenal hyperplasia require reassessment regarding the need for glucocorticoid drug treatment. No clinical trials have compared various regimens for classic congenital adrenal hyperplasia in adults, thus therapy is individualised and based on the prevention of adverse outcomes. Extensive patient education is key during transition from paediatric care to adult care and should include education of females with classic congenital adrenal hyperplasia regarding their genital anatomy and surgical history. Common issues for these patients include urinary incontinence, vaginal stenosis, clitoral pain, and cosmetic concerns; for males with classic congenital adrenal hyperplasia, common issues include testicular adrenal rest tumours. Transition from paediatric to adult care is most successful when phased over many years. Education of health-care providers on how to successfully transition patients is greatly needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2213-8587(13)70138-4

Cites

107 of 107 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Patients with classic 21OH deficiency also have epinephrine deficiency, due to abnormal adrenomedullary formation; this places patients at risk for hypoglycemia, especially when fasting, or during acute illness.

    “Patients with classic 21OH deficiency also have epinephrine deficiency, due to abnormal adrenomedullary formation; 73 this places patients at risk for hypoglycemia, especially when fasting, or during acute illness.”

    From Congenital adrenal hyperplasia (2017) · cites this paper as [73]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 108 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. [55]Rivkees SA Lost lessons of glucocorticoid potency and the treatment of children with congenital adrenal hyperplasia J Pediatr Endocrinol Metab 2008 21 297 99 18556959

Cited by

Sorted by citations

Authors
Merke, D. P., & Poppas, D. P.
Affiliations
  • National Institutes of Health (US)
  • NewYork–Presbyterian Hospital (US)
Corresponding author
Merke, Deborah P
Venue
The Lancet Diabetes & Endocrinology
Publisher
Elsevier BV
Published
2013-12
Volume
1
Issue
4
Pages
341-352
ISSN
2213-8587 (ISSN-L)
OpenAlex
W2149437278
Cited by
134
References
108
Citations by year
2026: 6 · 2025: 6 · 2024: 12 · 2023: 11 · 2022: 30 · 2021: 13 · 2020: 6 · 2019: 11 · 2018: 12 · 2017: 11 · 2016: 8 · 2015: 6 · 2012: 1
FWCI
0.44
Type
journal article
Language
en
Open access
Locations
  • The Lancet Diabetes & Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institutes of Health (Z99CL999999)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sexual Differentiation and Disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Keywords
congenital adrenal hyperplasia, adolescents, puberty, androgen deprivation therapy, glucocorticoid therapy, non-classical congenital adrenal hyperplasia, adrenal insufficiency, medication adherence, sexual function, transition to adult care, patient education, urinary incontinence, vaginal stenosis, clitoral pain, personalized treatment
MeSH terms
Adolescent, Adrenal Hyperplasia, Congenital, Glucocorticoids, Humans, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review